期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Determination of JBP485 by LC/MS and its pharmacokinetics in rats
1
作者 CANG Jian,WANG Chang-yuan,LIU Qi,ZHANG Jian,LIU Ke-xin(College of pharmacy,Dalian Medical University,Dalian 116044,China) 《沈阳药科大学学报》 CAS CSCD 北大核心 2008年第S1期100-100,共1页
Objective Cyclo-trans-4-L-hydroxyprolyl-L-serine(JBP485)is a dipeptide isolated from Laennec,and Laennec is a hydrolyzate of human placenta.Evidence has indicated that JBP485 exhibited potent anti-hepatitis activity.I... Objective Cyclo-trans-4-L-hydroxyprolyl-L-serine(JBP485)is a dipeptide isolated from Laennec,and Laennec is a hydrolyzate of human placenta.Evidence has indicated that JBP485 exhibited potent anti-hepatitis activity.In this study,we developed a method for rapid and sensitive determination of JBP485 in rat biologic samples by LC/MS,and then studied its pharmacokinetics.We investigated the main excretion pathway of JBP485.Methods Following protein-precipitation with methanol,the analyte and internal standard(Paracetamol)were separated from rat plasma using an isocratic mobile phase on an Cap cell pack C18 UG120 column with a mobile phase consisting of methanol-water-formic acid(30∶70∶0.2,V∶V∶V)at a flow rate of 0.5 mL·min-1.An API 3200 tandem mass spectrometer equipped with Turbo Ion Spray ionization source was used as detector and was operated in the positive ion mode.Multiple reaction monitoring transporter precursor to product ion combinations of m/z 201.1→86.1 and m/z 152.1→110.1 were performed to quantify JBP485 and internal standard,respectively.After JBP485 was injected intravenously at a dose of 25 mg·kg-1 to rats,blood,bile and urine was collected at different time up to 8 h.The plasma concentration-time curve was plotted.The main pharmacokinetic parameters of JBP485 were obtained by 3P97 software.Results Linear calibration was generated over a concentration range of 0.1-200 μg·mL-1 for biologic samples by using LC/MS,with the lower limit of quantification of 0.1 μg·mL-1.Intra-and inter-days precision and accuracy were acceptable for all quality control samples.The mean recovery of JBP485 was above 90%,respectively.Pharmacokinetic parameters were estimated as follows:AUC(9103.96±513.85)μg·min·mL-1,t1/2β(77.98±4.06)min and CL(0.002±0.0001)mL·kg-1·min-1.The cumulative urinary excretion for 8 hours after administration was 30% of the dose.The cumulative biliary excretion for 8 hours after administration was 2%.Conclusions The LC/MS method was suitable for the pharamacokinetic study of JBP485 in rat with the advantages of specificity,sensitivity,accuracy and high speed.Renal excretion was the main excretive route of JBP485. 展开更多
关键词 jbp485 LC/MS TRANSPORTER pharamacokinetics
下载PDF
羟丝肽口服微乳的制备与体内药动学研究 被引量:2
2
作者 李磊 王长远 +3 位作者 蔡芸 高鹏程 田燕 刘克辛 《医药导报》 CAS 北大核心 2014年第2期135-139,共5页
目的 制备羟丝肽(JBP 485)口服微乳,并考察其形态、稳定性及体内药动学性质.方法采用伪三元相图绘制法来筛选JBP 485微乳制备的处方,以微乳的载药量、稳定性及黏度作为综合评定的指标,优选最佳处方.给大鼠分别灌胃JBP 485水溶液和JBP ... 目的 制备羟丝肽(JBP 485)口服微乳,并考察其形态、稳定性及体内药动学性质.方法采用伪三元相图绘制法来筛选JBP 485微乳制备的处方,以微乳的载药量、稳定性及黏度作为综合评定的指标,优选最佳处方.给大鼠分别灌胃JBP 485水溶液和JBP 485微乳,比较药物在大鼠体内的生物利用度.结果筛选出JBP 485微乳的最佳处方,以三油酸甘油酯-单辛/癸酸甘油酯(ODO-L)-乙醇-水(Km=1:1)体系作为JBP 485微乳的载药体系,JBP 485微乳热力学稳定性良好,粒径60~120 nm,载药量35 μg·mL-1.药动学结果表明所制备的JBP 485微乳在大鼠体内的相对生物利用度达到191.3%.结论制备的JBP 485微乳稳定性良好,相对于水溶液,生物利用度有较明显的提高. 展开更多
关键词 羟丝肽 微乳 伪三元相图 生物利用度 药动学
下载PDF
羟丝肽口服PLGA纳米粒的制备、体外释药及体内药物代谢动力学研究
3
作者 李磊 王长远 刘克辛 《中南药学》 CAS 2016年第9期932-935,共4页
目的以生物可降解材料乳酸-乙醇酸共聚物(PLGA)制备羟丝肽(JBP 485)纳米粒,并考察其形态、体外释放及体内药物代谢动力学性质。方法采用复乳(W/O/W)-溶剂挥发法制备了JBP 485-PLGA纳米粒;用透射电镜观察纳米粒的形态,并对JBP 485-PLGA... 目的以生物可降解材料乳酸-乙醇酸共聚物(PLGA)制备羟丝肽(JBP 485)纳米粒,并考察其形态、体外释放及体内药物代谢动力学性质。方法采用复乳(W/O/W)-溶剂挥发法制备了JBP 485-PLGA纳米粒;用透射电镜观察纳米粒的形态,并对JBP 485-PLGA纳米粒的粒径与分布、载药量、包封率和体内外释药进行了研究。结果制得的JBP 485-PLGA纳米粒为类球形实体粒子,平均粒径为93nm,多分散指数(PDI)为0.167,载药量约为8%,包封率约为30%。经大鼠口服灌胃后,JBP 485水溶液组在体内半衰期(t1/2)仅为1.47 h,t_(max)为1 h,AUC为10.286μg·h·mL^(-1),而同剂量的JBP 485-PLGA纳米粒在体内t1/2为4 h,t_(max)为2 h,AUC为17.157μg·h·mL^(-1)。结论制得的JBP 485-PLGA纳米粒可改变JBP 485体内的药物代谢动力学行为,延长JBP 485在体内的循环时间,具有明显的缓释作用,口服吸收好,生物利用度有明显提高。 展开更多
关键词 乳酸-乙醇酸共聚物纳米粒 羟丝肽 生物利用度 体内药物代谢动力学
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部